Non-Coding RNAs and Wnt/β-Catenin Signaling Pathway in Gastric Cancer: From EMT to Drug Resistance
Onco · 2021
DOI: 10.3390/onco1020012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Onco, 2021. Verfasst von Bruno Takao Real Karia und 4 weiteren Autor:innen. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, National Council for Scientific and Technological Development, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
Gastric cancer is one of the most common cancers and the third cause of cancer-related death worldwide. The treatment of GC patients improved due to advancements in surgery, radiotherapy and chemotherapy. However, the long-term survival rate of patients with gastric cancer remains around 20%. Thus, development of novel therapeutic approaches is of great interest, in order to reduce the need for mutilating surgeries and morbid adjuvant therapies. For many years, it was believed that the RNA was a mere intermediate molecule in the genetic information flow. However, during the past decades, with the advent of new sequencing technologies, it was revealed that non-coding RNAs play important roles in many different biological processes. The Wnt/β-catenin signaling pathway has been reported to regulate crucial events during neoplasic development, such as cell differentiation, proliferation, invasion, migration, apoptosis, and angiogenesis. In this review, we will focus on microRNAs and long non-coding RNAs that have been implicated in gastric cancer tumorigenesis via modulation of the Wnt/β-catenin signaling pathway, which provided some biomarkers to prognosis, diagnosis, and therapy.
Förderung
- São Paulo Research Foundation
- National Council for Scientific and Technological Development
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
Zitieren
APA
Karia, B. T. R., Pinto, C. A., Gigek, C. O., Wisnieski, F., & Smith, M. A. C. (2021). Non-Coding RNAs and Wnt/β-Catenin Signaling Pathway in Gastric Cancer: From EMT to Drug Resistance. Onco. https://doi.org/10.3390/onco1020012
Vancouver
Karia BTR, Pinto CA, Gigek CO, Wisnieski F, Smith MAC. Non-Coding RNAs and Wnt/β-Catenin Signaling Pathway in Gastric Cancer: From EMT to Drug Resistance. Onco. 2021. doi:10.3390/onco1020012
BibTeX
@article{Karia2021,
author = {Karia, Bruno Takao Real and Pinto, Camila Albuquerque and Gigek, Carolina Oliveira and Wisnieski, Fernanda and Smith, Marilia Arruda Cardoso},
title = {Non-Coding RNAs and Wnt/β-Catenin Signaling Pathway in Gastric Cancer: From EMT to Drug Resistance},
journal = {Onco},
year = {2021},
doi = {10.3390/onco1020012}
}
EUVIMED